SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jagsonpal Pharmaceuticals informs about un-audited financial results

13 Feb 2019 Evaluate

Pursuant to Regulation 33(3)(d) read with Regulation 47(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jagsonpal Pharmaceuticals has informed about submission of the Certified True Copies of publication of Standalone Un-Audited Financial Results for the Quarter ended 31st December, 2018, approved at the meeting of the Board of Directors of the company held on 13th February, 2019 at the registered office of the company. Further, the publication was made in one English and Hindi Newspaper of Business Standard respectively.

The above information is a part of company’s filings submitted to BSE.

Jagsonpal Pharma Share Price

209.50 2.70 (1.31%)
06-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1850.40
Dr. Reddys Lab 1310.50
Cipla 1365.25
Zydus Lifesciences 939.10
Lupin 2442.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×